FUNCTIONAL GENOMICS CORE
FUNCTIONAL GENOMICS CORE
批准号:
7777675
负责人:
BRIAN Keith DIECKGRAEFE
金额:
$11.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2014-11-30
关键词:
AddressApoptosisAreaBindingBioinformaticsBiological ProcessBudgetsCellsChemotaxisClinicalCollectionCommitCommunitiesComplexCore FacilityDNA Microarray ChipDNA-Binding ProteinsDatabasesDevelopmentDigestive System DisordersDiseaseEquipmentEventExpressed Sequence TagsFundingFungal GenomeGene ExpressionGenesGenetic TranscriptionGenomeHepaticHumanHuman Genome ProjectHuman ResourcesInflammationInstitutionInvestigationInvestmentsLaboratoriesLibrariesLigandsLogicMalignant NeoplasmsMatrix MetalloproteinasesMeasuresMethodologyMethodsMicroRNAsMolecular ProfilingMonitorMorphologyMusNational Institute of General Medical SciencesOligonucleotidesPathologyPhysiological ProcessesPolysaccharidesProcessProtein ArrayProtein-Carbohydrate InteractionRattusResearchResearch PersonnelResourcesRoleSamplingServicesStreptavidinStructureTechnologyTimeTissue BankingTissue BanksTissue ProcurementsTissuesTrainingUniversitiesVirus DiseasesWashingtonWorkangiogenesisarmbasecDNA Arrayschromatin immunoprecipitationcostcost effectivedensitydesignexperiencefunctional genomicsfunctional groupgastrointestinalgenome sequencinginstrumentationlipid metabolismprogramspromoter
中文摘要
人类基因组计划和表达序列标签(EST)克隆收集的发展
英文摘要
The Human Genome Project and the development of the expressed sequence tag (EST) clone collection
and database have revolutionized gene expression analysis. Instead of measuring one or a few genes, parallel
DNA microarrays are capable of simultaneously measuring expression of thousands of genes, providing a
glimpse into the logic and functional grouping of gene programs encoded by our genome. The term functional
genomics encompasses varied approaches that provide a more global investigation into the expression and
role of groups of genes in a physiologic process than has been previously available. As such, this approach
represents a fundamental shift from the traditional 'one gene at a time' approach to the study of basic biological
processes. cDNA microarrays and oligonucleotide-based microarray methodologies have the potential to
provide a new level of information about cell or tissue function not previously possible. However, these
technologies require an investment in expensive equipment and highly trained, experienced technicians. Most
laboratories cannot afford to commit the substantial technical resources and personnel to the development and
ongoing refinement of these particularly complex experimental methods. It is more cost effective to concentrate
this instrumentation and highly skilled technical support in a centrally managed facility, where they will be
efficiently utilized and cost effective. The Functional Genomics Core Facility was designed to provide this
critical core expertise to the digestive disease research community.
The unique feature of the Functional Genomics Core Facility is the expertise it provides to participating
investigators on the application of high density comprehensive arrays to study gastrointestinal and hepatic
qene expression. In maintaining an independent microarray core, DDRCC research investigators are provided
with access to the Agilent platforms at extremely low costs ($275/2 sample comparisons using the 44K gene
arrays) and with much more rapid turn around time (<5 days) than other microarray facilities in the institution.
The close proximity of the Functional Genomics Core to the DDRCC Morphology Core and the DDRCC Tissue
Procurement Facility greatly facilitates the processing and analysis of clinical samples related to digestive
disease disorders. The DDRCC Functional Genomics Core works closely with other microarray facilities at this
institution that offer alternative commercial platforms, such as the Affymetrix platforms supported by the CTSA
sponsored Translational Pathology and Tissue Banking Core, and the Illumina platforms supported by the
Genome Sequencing Center of Washington University. Important for tight budgets, the cost of our services is
less than half the cost of a single sample Affy array, and is about 20% less than the Illumina platform. Just as
important, the Functional Genomics Core provides integrative and bioinformatic services.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Reg4-CD44 Signaling Pathway in Colon Cancer
-
批准号:9339585
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Novel Reg4-CD44 Signaling Pathway in Colon Cancer
-
批准号:9795436
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
-
批准号:7263699
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2007
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
-
批准号:8050129
-
项目类别:
-
资助金额:$36.54万
-
财政年份:2007
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
-
批准号:7406643
-
项目类别:
-
资助金额:$37.28万
-
财政年份:2007
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
-
批准号:7585280
-
项目类别:
-
资助金额:$37.28万
-
财政年份:2007
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Mechanisms of Action for Colony-Stimulating-Factors In IBD
-
批准号:7796657
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2007
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
EXPRESS REGENERATING GENE FAMILY IN IBD MUCOSA REG IA UPREGULATION
-
批准号:7180057
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2005
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
CORE F: FUNCTIONAL GENOMICS FACILITY
-
批准号:6827141
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2004
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
EXPRESS REGENERATING GENE FAMILY IN IBD MUCOSA REG IA UPREGULATION
-
批准号:6977024
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2003
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Study of Reg Receptor-Ligand Biology in the GI Mucosa
-
批准号:6477948
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2002
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Study of Reg Receptor-Ligand Biology in the GI Mucosa
-
批准号:6862769
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2002
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
STUDY OF REG RECEPTOR-LIGAND BIOLOGY IN GI MUCOSA
-
批准号:8209296
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2002
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
STUDY OF REG RECEPTOR-LIGAND BIOLOGY IN GI MUCOSA
-
批准号:8402654
-
项目类别:
-
资助金额:$30.13万
-
财政年份:2002
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
STUDY OF REG RECEPTOR-LIGAND BIOLOGY IN GI MUCOSA
-
批准号:8053350
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2002
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Study of Reg Receptor-Ligand Biology in the GI Mucosa
-
批准号:7024509
-
项目类别:
-
资助金额:$24.28万
-
财政年份:2002
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Study of Reg Receptor-Ligand Biology in the GI Mucosa
-
批准号:6710602
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2002
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
STUDY OF REG RECEPTOR-LIGAND BIOLOGY IN GI MUCOSA
-
批准号:7784310
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2002
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
Study of Reg Receptor-Ligand Biology in the GI Mucosa
-
批准号:6625671
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2002
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
STUDY OF REG RECEPTOR-LIGAND BIOLOGY IN GI MUCOSA
-
批准号:7624106
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2001
-
负责人:BRIAN Keith DIECKGRAEFE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: